Vaccination against “omicron” strain have been introduced

According to the French biotechnology company “Valneva”, preliminary studies on three doses VLA2001 has been proven to affect efficiently “omicron” strain with neutralizing.

German scientists have identified the contingency of vaccination against COVID-19 using several drugs.

According to scientists, when a person gets inoculated with two distinct medications, the likelihood of having adverse effects boosts.

Pursuant to research corollary, the vaccine may reduce long-term COVID-19 cases

A new study indicated that the long-term incidence of COVID-19 significantly abated among those who received the two-dose vaccine and those who were infected with the virus compared to people who had not previously been vaccinated.